Ezrin has been suggested to contribute in PTC to the uptake by micropinocytosis of advanced glycation end products (which results from the non-enzymatic glycation of proteins during chronic hyperglycemia and contribute to DKD) [58] and thereby to promote diabetes-induced tubulointerstitial fibrosis [59]. This evidence concerns the gene EZR and diabetic kidney disease.